News|Podcasts|August 2, 2023
The Business Case for Patient Centricity
Author(s)ZS Associates
Sharon Suchotliff, associate principal at ZS and lead for patient centricity, discusses why patient centricity has become a business imperative for life sciences companies. Sharon delves into the measurement of patient centricity, provides examples of how different companies have approached this and ZS’s approach for Patient Outcomes Impact (POI).
Related Content
Trending on PharmExec
1
Pharmaceutical Executive Daily: Unpacking IRA-Driven Formulary Pressure
2
From Pilot to Profit: How Pharma Leaders Are Scaling AI Across the Drug Lifecycle
3
President Trump Set to Nominate Heidi Overton as FDA Commissioner
4
When Drug Pricing Becomes Trade Policy
5